Reference
Li D-L, et al. Long-lasting response to third-line crizotinib treatment in a patient with non-small cell lung cancer with brain metastases and poor performance status. Thoracic Cancer 7: 619-622, No. 5, 12 Aug 2016. Available from: URL: http://doi.org/10.1111/1759-7714.12383 - China
Rights and permissions
About this article
Cite this article
Cisplatin. Reactions Weekly 1633, 198 (2017). https://doi.org/10.1007/s40278-017-24468-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-24468-3